| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042512609 |
| P356 | DOI | 10.1007/S00467-016-3505-3 |
| P698 | PubMed publication ID | 27704252 |
| P50 | author | Maren Leifheit-Nestler | Q57132563 |
| P2093 | author name string | Dieter Haffner | |
| P2860 | cites work | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 |
| Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein | Q24309454 | ||
| Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 | ||
| Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes | Q24604832 | ||
| Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold | Q26781354 | ||
| FGF23 signaling impairs neutrophil recruitment and host defense during CKD. | Q27330325 | ||
| Fibroblast growth factors, their receptors and signaling | Q28140520 | ||
| Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain | Q28141252 | ||
| Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production | Q28213962 | ||
| Klotho converts canonical FGF receptor into a specific receptor for FGF23 | Q28272505 | ||
| Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo | Q28572995 | ||
| Cognitive impairment in chronic kidney disease: keep vascular disease in mind | Q33898155 | ||
| Effect of niacin on FGF23 concentration in chronic kidney disease | Q33914268 | ||
| Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis | Q33932297 | ||
| Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers | Q33974129 | ||
| FGF23 protein expression in coronary arteries is associated with impaired kidney function. | Q33985430 | ||
| Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice | Q57184568 | ||
| Effects of niceritrol on faecal and urinary phosphate excretion in normal rats | Q57224002 | ||
| Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells | Q58363704 | ||
| Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal Transplantation | Q58946285 | ||
| Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial | Q58946610 | ||
| Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study | Q59575076 | ||
| In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome | Q64380372 | ||
| Clinical and echocardiographic disease in patients starting end-stage renal disease therapy | Q72192935 | ||
| Physiology and biochemistry of endothelial function in children with chronic renal failure | Q73604837 | ||
| Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients | Q80078924 | ||
| Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism | Q81251002 | ||
| Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community | Q83268557 | ||
| Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients | Q83898059 | ||
| ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction | Q84314698 | ||
| Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma | Q84401088 | ||
| Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis | Q84403337 | ||
| A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease | Q85396196 | ||
| Key role of the kidney in the regulation of fibroblast growth factor 23 | Q85670159 | ||
| Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients | Q87204432 | ||
| Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients | Q87389519 | ||
| Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community | Q95407461 | ||
| FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. | Q54733425 | ||
| Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population | Q34018038 | ||
| The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. | Q34022484 | ||
| Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease | Q34025119 | ||
| Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease | Q34027316 | ||
| FGF23 induces left ventricular hypertrophy | Q34028891 | ||
| FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy | Q34035797 | ||
| Fibroblast growth factor-23 and cardiac structure and function | Q34039877 | ||
| FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. | Q34130840 | ||
| Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. | Q34197301 | ||
| Phosphorus is associated with coronary artery disease in patients with preserved renal function | Q34271082 | ||
| A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. | Q34412241 | ||
| Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study | Q34557041 | ||
| Expression and functions of fibroblast growth factor 2 (FGF-2) in hippocampal formation. | Q34620993 | ||
| Arterial klotho expression and FGF23 effects on vascular calcification and function | Q34663898 | ||
| Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. | Q34727978 | ||
| Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease | Q35067500 | ||
| Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium | Q35138667 | ||
| Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease | Q35210184 | ||
| FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis | Q35272291 | ||
| Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate | Q35550609 | ||
| FGF-23 and cognitive performance in hemodialysis patients | Q35647125 | ||
| Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism | Q35682152 | ||
| Cardiovascular disease in children with chronic kidney disease | Q35853321 | ||
| Oxidative stress in uremia: nature, mechanisms, and potential consequences | Q35921174 | ||
| IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients | Q35983464 | ||
| Calcium deficiency reduces circulating levels of FGF23. | Q36050923 | ||
| Fibroblast growth factor 23 and Inflammation in CKD | Q36067879 | ||
| FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality | Q36068303 | ||
| Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. | Q36104887 | ||
| Effects of phosphate binders in moderate CKD | Q36109201 | ||
| Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy | Q36348861 | ||
| Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD. | Q36417881 | ||
| Frequency of and risk factors for poor cognitive performance in hemodialysis patients | Q36661833 | ||
| Regulation of oxidative stress by the anti-aging hormone klotho | Q36835699 | ||
| Fibroblast growth factor 23 is not associated with and does not induce arterial calcification | Q36901897 | ||
| Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood. | Q37131179 | ||
| Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation | Q37280819 | ||
| Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages. | Q37365288 | ||
| Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis | Q37542837 | ||
| Disordered FGF23 and mineral metabolism in children with CKD | Q37553097 | ||
| Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. | Q37621547 | ||
| Left ventricular mass in chronic kidney disease and ESRD. | Q37649218 | ||
| Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies | Q38034690 | ||
| Klotho and chronic kidney disease | Q38104935 | ||
| FGF23 and Klotho in chronic kidney disease | Q38105949 | ||
| Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. | Q38200883 | ||
| Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial | Q38410120 | ||
| FGF23 from bench to bedside. | Q38728860 | ||
| Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults | Q39605259 | ||
| Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children. | Q39887303 | ||
| Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors | Q40749434 | ||
| Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients | Q40846380 | ||
| Is peritoneal dialysis still an equal option? Results of the Berlin pediatric nocturnal dialysis program | Q41067602 | ||
| Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice | Q41295557 | ||
| Early kidney transplantation improves neurocognitive outcome in patients with severe congenital chronic kidney disease | Q41627774 | ||
| Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23. | Q42492760 | ||
| The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers | Q42860478 | ||
| FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease | Q42976674 | ||
| Hunt for the culprit of cardiovascular injury in kidney disease | Q43207404 | ||
| Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a Doppler echocardiography study | Q43643568 | ||
| Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia | Q44203982 | ||
| Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia | Q44414604 | ||
| Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis | Q44779387 | ||
| Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis | Q44871721 | ||
| Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. | Q45233297 | ||
| High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. | Q46035991 | ||
| Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients | Q46567248 | ||
| Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism | Q46585085 | ||
| Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. | Q46680438 | ||
| Pathogenic role of Fgf23 in Hyp mice. | Q46921328 | ||
| Klotho protein protects against endothelial dysfunction | Q47799420 | ||
| High serum phosphorus and FGF 23 levels are associated with progression of coronary calcifications | Q47843993 | ||
| Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density. | Q48891787 | ||
| Neurocognitive Dysfunction in Children, Adolescents, and Young Adults With CKD. | Q50701502 | ||
| Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. | Q52894312 | ||
| Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease. | Q53149178 | ||
| Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. | Q53455976 | ||
| Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment. | Q53810866 | ||
| Fibroblast growth factor receptor 4: the missing link between chronic kidney disease and FGF23-induced left ventricular hypertrophy? | Q54222679 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 753-765 | |
| P577 | publication date | 2016-10-04 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Extrarenal effects of FGF23. | |
| P478 | volume | 32 |
| Q63977287 | Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients |
| Q91679948 | Association of Intracranial Artery Calcification with Cognitive Impairment in Hemodialysis Patients |
| Q48323760 | Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs |
| Q55413743 | Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23. |
| Q90433020 | Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease |
| Q55221465 | Paracrine Effects of FGF23 on the Heart. |
| Q90264158 | Phosphate wasting disorders in adults |
| Q37742955 | The High Calcium, High Phosphorus Rescue Diet Is Not Suitable to Prevent Secondary Hyperparathyroidism in Vitamin D Receptor Deficient Mice |
Search more.